262 related articles for article (PubMed ID: 20082507)
1. Drug pricing in AFP--how much does a drug cost?
Siwek J
Am Fam Physician; 2010 Jan; 81(2):125. PubMed ID: 20082507
[No Abstract] [Full Text] [Related]
2. [Parallel import of drugs for better and for worse].
Krabbe U
Ugeskr Laeger; 2004 Feb; 166(7):611. PubMed ID: 15005051
[No Abstract] [Full Text] [Related]
3. To cut costs, risky drug use.
Consum Rep; 2011 Nov; 76(11):9. PubMed ID: 22022754
[No Abstract] [Full Text] [Related]
4. The elephant in the pharmacy: patient choice is the big challenge that no one talks about in affordability of prescription drugs.
Fairman KA; Curtiss FR
J Manag Care Pharm; 2007 Sep; 13(7):620-2. PubMed ID: 17874872
[No Abstract] [Full Text] [Related]
5. Best medicines for less: we compare drugs for what ails America.
Consum Rep; 2008 Jan; 73(1):27-9. PubMed ID: 18488284
[No Abstract] [Full Text] [Related]
6. State prescription drug price Web sites: how useful to consumers?
Tu HT; Corey CG
Res Brief; 2008 Feb; (1):1-16. PubMed ID: 18494180
[TBL] [Abstract][Full Text] [Related]
7. The high price of prescription drugs and its impact on the elderly.
McCloskey A
Care Manag J; 2002; 3(3):143-53. PubMed ID: 12632881
[No Abstract] [Full Text] [Related]
8. The effects of copayments and generic substitution on the use and costs of prescription drugs.
Smith DG
Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607
[TBL] [Abstract][Full Text] [Related]
9. Patients who pay out-of-pocket receive lower-cost drugs.
Am J Health Syst Pharm; 1998 Aug; 55(15):1556-8. PubMed ID: 9706178
[No Abstract] [Full Text] [Related]
10. Medicare prescription plan, threat to AWP could impact the ESRD drug market.
Neumann ME
Nephrol News Issues; 2003 Jan; 17(2):16-7, 21. PubMed ID: 12629823
[No Abstract] [Full Text] [Related]
11. Pandora's Prescription: The Pharmaceutical Pricing
Pederson T
FASEB J; 2017 Nov; 31(11):4661-4662. PubMed ID: 29093000
[No Abstract] [Full Text] [Related]
12. [Generic medicines].
Peláez de Loño J
Rev Enferm; 1999 Dec; 22(12):836-43. PubMed ID: 10797771
[TBL] [Abstract][Full Text] [Related]
13. Potential savings from generic prescribing and generic substitution in South Africa.
Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS
Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460
[TBL] [Abstract][Full Text] [Related]
14. Favorable Formulary Placement of Branded Drugs in Medicare Prescription Drug Plans When Generics Are Available.
Socal MP; Bai G; Anderson GF
JAMA Intern Med; 2019 Jun; 179(6):832-833. PubMed ID: 30882842
[TBL] [Abstract][Full Text] [Related]
15. Consumers devise drug cost-cutting measures: medical and legal issues to consider.
Ganguli G
Health Care Manag (Frederick); 2003; 22(3):275-81. PubMed ID: 12956230
[TBL] [Abstract][Full Text] [Related]
16. Four-dollar generics--increased accessibility, impaired quality assurance.
Choudhry NK; Shrank WH
N Engl J Med; 2010 Nov; 363(20):1885-7. PubMed ID: 21067379
[No Abstract] [Full Text] [Related]
17. Prices of 18 new drug formulations are capped in India.
Travasso C
BMJ; 2015 Nov; 351():h6006. PubMed ID: 26553651
[No Abstract] [Full Text] [Related]
18. The cost and availability of prescription drugs--what can we do in Massachusetts?
Carpenter NW; Kedikoglou S
Issue Brief (Mass Health Policy Forum); 1999 May; (4):1-41. PubMed ID: 12769091
[No Abstract] [Full Text] [Related]
19. Increasing generic drug use in Medicare Part D: the role of government.
Kohl H; Shrank WH
J Am Geriatr Soc; 2007 Jul; 55(7):1106-9. PubMed ID: 17608887
[No Abstract] [Full Text] [Related]
20. [[Prescriptions for psychotropic drugs: results and comments on the 2007 prescription drug report].
Fritze J
Nervenarzt; 2008 Nov; 79(11):1337-45. PubMed ID: 19002733
[No Abstract] [Full Text] [Related]
[Next] [New Search]
